Literature DB >> 944387

Mental symptoms in Parkinson's disease during chronic treatment with levodopa.

R D Sweet, F H McDowell, J S Feigenson, A W Loranger, H Goodell.   

Abstract

Mental symptoms increased in frequency among 100 patients with parkinsonism treated with levodopa. Dementia was found in about one-third of patients throughout the 6-year treatment period. Thirteen patients became demented during the study, and dementia worsened severely in seven others. Agitated confusion became increasingly frequent and was observed in 60 percent of patients taking levodopa for 6 years. Withdrawal from levodopa decreased agitation, but not dementia. Ten patients received L-tryptophan along with levodopa, but no change in mentation was observed. In view of previous studies of mentation in Parkinson's disease and reports of widespread neuronal changes in the brain of autopsied patients with parkinsonism, our results suggest that the high incidence of dementia in patients with Parkinson's disease who take levodopa reflects prolongation of the course of the illness rather than a direct effect of the medication.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 944387     DOI: 10.1212/wnl.26.4.305

Source DB:  PubMed          Journal:  Neurology        ISSN: 0028-3878            Impact factor:   9.910


  19 in total

Review 1.  Deterioration of dopaminergic pathways and alterations in cognition and motor functions.

Authors:  B Dubois; B Pillon; Y Agid
Journal:  J Neurol       Date:  1992       Impact factor: 4.849

Review 2.  Psychotic symptoms in Parkinson's disease. From description to etiology.

Authors:  Spiridon Papapetropoulos; D C Mash
Journal:  J Neurol       Date:  2005-07       Impact factor: 4.849

3.  L-Tryptophan: Biochemical, nutritional and pharmacological aspects.

Authors:  E L Sainio; K Pulkki; S N Young
Journal:  Amino Acids       Date:  1996-03       Impact factor: 3.520

Review 4.  Pineal melatonin and sensory symptoms in Parkinson disease.

Authors:  R Sandyk
Journal:  Ital J Neurol Sci       Date:  1989-08

Review 5.  Organic psychosis: Insight into the biology of psychosis.

Authors:  N T Lautenschlager; H Förstl
Journal:  Curr Psychiatry Rep       Date:  2001-08       Impact factor: 5.285

6.  Influence of certain factors on the manifestations of the adverse effects of metrizamide myelography.

Authors:  Y L Yu; G H du Boulay; E Paul
Journal:  Neuroradiology       Date:  1986       Impact factor: 2.804

7.  Treatment of the on-off syndrome in Parkinsonism with low dose bromocriptine in combination with levodopa.

Authors:  D N Bateman; A Coxon; N J Legg; J L Reid
Journal:  J Neurol Neurosurg Psychiatry       Date:  1978-12       Impact factor: 10.154

8.  Differing patterns of psychiatric impairment in Alzheimer and demented parkinsonian patients.

Authors:  P Soliveri; M B Zappacosta; L Austoni; P Caffarra; A Scaglioni; D Testa; E Palazzini; T Caraceni; F Girotti
Journal:  Ital J Neurol Sci       Date:  1994-11

9.  Treatment of drug-induced exogenous psychosis in parkinsonism with clozapine and fluperlapine.

Authors:  E Scholz; J Dichgans
Journal:  Eur Arch Psychiatry Neurol Sci       Date:  1985

Review 10.  Treating Hallucinations and Delusions Associated With Parkinson's Disease Psychosis.

Authors:  Shyam C Panchal; William G Ondo
Journal:  Curr Psychiatry Rep       Date:  2018-01-27       Impact factor: 5.285

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.